サンプル依頼リスト カート
  • English
  • Korean
表紙：脊椎固定装置の世界市場：2023-2030
市場調査レポート
商品コード
1290359

脊椎固定装置の世界市場：2023-2030

Global Spinal Fusion Devices Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脊椎固定装置の世界市場：2023-2030
出版日: 2023年06月12日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

脊椎固定装置の世界市場規模は、2022年に76億6,640万米ドルに達し、2030年には最大108億2,740万米ドルに達することで有利な成長が予測されています。脊椎固定装置の世界市場は、予測期間中（2023年～2030年）に4.5%のCAGRを記録しています。

脊椎固定術は通常、変性椎間板症、脊柱管狭窄症、脊椎骨折、脊柱管狭窄症、脊椎不安定症など、さまざまな脊椎疾患の治療のために行われます。この手術では、インプラントや骨移植を使用して2つ以上の隣接する椎骨を接合または融合させ、それらの間に強固な骨ブリッジを形成します。

脊椎固定装置市場は、高齢化社会と肥満人口の増加、認知度の向上と患者教育、脊椎疾患の有病率の増加、技術の進歩、低侵襲手術への嗜好の高まりといった要因によって牽引されています。

市場力学

脊椎疾患の有病率の増加

脊椎疾患の有病率の増加は、予測期間中の脊椎固定装置市場シェアを押し上げる主要因です。高齢化、座りがちなライフスタイル、肥満は、脊椎固定装置のチャンスを生み出す主な要因となっています。

世界人口の高齢化が進むにつれて、脊椎疾患の有病率は上昇すると予想されます。変性椎間板症や脊柱管狭窄症などの加齢に伴う変性疾患は、年齢が進むにつれてより一般的になります。椎間板、関節、靭帯などの脊椎構造の変性は、痛み、可動性の低下、脊椎の不安定性につながる可能性があります。

肥満の増加は、脊椎疾患のリスク上昇と強く関連しています。過剰な体重は脊椎にさらなるストレスを与え、脊椎構造の摩耗や損傷を加速させ、変性椎間板症や変形性脊椎症などの疾患を発症する可能性が高くなります。

高額な治療費

高い治療費は脊椎固定術の分野における重要な抑制要因であり、患者、ヘルスケアシステム、脊椎固定装置の導入に影響を与える可能性があります。脊椎固定術は複雑な手術であり、専門の医療従事者のチーム、高度な手術機器、術後ケアが必要です。手術の費用には、手術室、麻酔、外科医の費用、入院、リハビリテーションに関わる費用が含まれます。

これらの費用は、手術の複雑さ、ヘルスケア施設の所在地、患者さんの特定のニーズなどの要因によって異なる場合があります。新しい脊椎固定装置や技術の開発には、多大な研究開発努力が必要であり、それが治療費の上昇につながることもあります。これらの費用は、しばしば患者やヘルスケアシステムに転嫁されます。

COVID-19の影響分析

COVID-19の大流行は、脊椎固定装置市場に大きな影響を及ぼしました。脊椎固定術に携わる脊椎外科医やヘルスケア専門家は、患者のケア、研究、ワクチン接種の取り組みなど、COVID-19関連の活動に振り向けられました。このような優先順位やリソースのシフトにより、脊椎固定術の減少や新しい機器や技術の採用が一時的に鈍化した可能性があります。

病院は、ヘルスケア環境でのウイルス感染に対する懸念や、入院や術後ケアに関連するリスクの認識から、パンデミック時に選択的手術を受けることをためらっています。このような脊椎固定術への消極的な姿勢は、脊椎固定術用器具の需要減少にさらに貢献した可能性があります。

ワクチン接種が進み、ヘルスケアシステムがパンデミックの影響から回復するにつれ、延期された脊椎固定術のバックログが発生すると予想されます。このような需要の滞留と、選択的手術の再開とが相まって、パンデミック後の脊椎固定装置の需要回復につながる可能性があります。

ロシア・ウクライナ紛争分析

ロシア・ウクライナ紛争は、脊椎固定装置市場に大きな影響を与えました。紛争は、通貨変動、インフレ、購買力の低下など、経済的に大きな影響を与える可能性があります。これらの経済的要因はヘルスケア予算に影響を与え、脊椎固定装置を含む医療機器への支出減少につながる可能性があります。

紛争は、脊椎固定装置を含む医療機器のサプライチェーンを混乱させる可能性があります。両国はヘルスケア製品の製造と流通において重要な役割を担っています。輸送ルートの混乱、国境の閉鎖、政治的緊張は、脊椎固定装置の入手の遅延や中断につながる可能性があります。

目次

第1章 調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 製品タイプ別スニペット（Snippet by Product Type
  • 施術部位別スニペット
  • スニペット：アプリケーション別
  • エンドユーザー別スニペット
  • 地域別スニペット

第4章 市場力学

  • 影響要因
    • 促進要因
      • 脊椎疾患の有病率の増加
      • 低侵襲手術に対する需要の増加
    • 抑制要因
      • 高い治療費
      • 代替治療法の利用可能性
    • 機会
      • 手術手技の進歩
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 法規制の分析

第6章 COVID-19の分析

  • COVID-19の分析
    • COVID-19の前のシナリオ
    • COVID-19実施中のシナリオ
    • COVID-19後のシナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • サマリー

第7章 製品タイプ別

  • 椎弓根スクリュー
  • プレート
  • 骨移植
  • 脊椎固定術用刺激装置
  • その他

第8章 手術部位別

  • 頸椎椎間板ヘルニア治療器
  • 腰椎椎間板ヘルニア治療器
  • 胸部脊椎固定装置
  • その他

第9章 アプリケーション別

  • 椎間板変性疾患
  • 脊椎すべり症
  • 脊柱管狭窄症
  • 側湾症
  • 脊椎外傷
  • 腫瘍
  • その他

第10章 エンドユーザー別

  • 病院
  • 外来外科クリニック
  • 専門医院
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第13章 企業プロファイル

  • Medtronic plc
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Johnson & Johnson
  • Stryker Corporation
  • NuVasive Inc.
  • Zimmer Biomet Holdings Inc.
  • Globus Medical Inc.
  • Spinal Elements Inc.
  • Xtant Medical Holdings Inc.
  • RTI Surgical Inc.
  • ATEC spine Inc.

第14章 付録

目次
Product Code: MD1636

Market Overview

The Global Spinal Fusion Devices Market size reached US$ 7,666.4 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 10,827.4 million by 2030. The global spinal fusion devices market is exhibiting a CAGR of 4.5% during the forecast period (2023-2030).

Spinal fusion is typically performed to treat various spinal conditions, including degenerative disc disease, spinal stenosis, spinal fractures, scoliosis, and spinal instability. The procedure involves joining or fusing two or more adjacent vertebrae using implants or bone grafts to create a solid bone bridge between them.

The spinal fusion devices market is driven by factors such as the rising aging population and obese population, growing awareness and patient education, increasing prevalence of spinal disorders, technological advancements, and growing preference for minimally invasive procedures.

Market Dynamics

Increasing Prevalence of Spinal Disorders

The increasing prevalence of spinal disorders is the major factor driving the spinal fusion devices market share during the forecast period. The aging population, sedentary lifestyle, and obesity are the major factors leading to creating a chance for spinal fusion devices.

As the global population continues to age, the prevalence of spinal disorders is expected to rise. Age-related degenerative conditions, such as degenerative disc disease and spinal stenosis, become more common with advancing age. The degeneration of spinal structures, including discs, joints, and ligaments, can lead to pain, loss of mobility, and spinal instability.

The rising prevalence of obesity is strongly linked to an increased risk of spinal disorders. Excess weight places additional stress on the spine, leading to accelerated wear and tear of spinal structures and an increased likelihood of developing conditions such as degenerative disc disease and spinal osteoarthritis.

High Treatment Costs

High treatment costs are a significant restraint in the field of spinal fusion and can impact patients, healthcare systems, and the adoption of spinal fusion devices. Spinal fusion surgery is a complex procedure that involves a team of specialized healthcare professionals, advanced surgical equipment, and postoperative care. The cost of the surgery includes expenses related to the operating room, anesthesia, surgeon fees, hospital stay, and rehabilitation.

These costs can vary depending on factors such as the complexity of the procedure, the location of the healthcare facility, and the patient's specific needs. The development of new spinal fusion devices and technologies involves significant research and development efforts, which can contribute to higher treatment costs. These costs are often passed on to patients and healthcare systems.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the spinal fusion devices market. Spinal surgeons and healthcare professionals involved in spinal fusion procedures were redirected to COVID-19-related activities, including patient care, research, and vaccination efforts. This shift in priorities and resources could have resulted in a decrease in spinal fusion surgeries and a temporary slowdown in the adoption of new devices or technologies.

Patients were hesitant to undergo elective surgeries during the pandemic due to concerns about contracting the virus in healthcare settings or the perceived risk associated with hospitalization and postoperative care. This reluctance to undergo spinal fusion procedures may have further contributed to the decline in demand for spinal fusion devices.

As vaccination efforts progress and healthcare systems recover from the pandemic's impact, there is expected to be a backlog of deferred spinal fusion surgeries. This pent-up demand, coupled with the resumption of elective surgeries, could lead to a rebound in the demand for spinal fusion devices in the post-pandemic period.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict significantly impacted the spinal fusion devices market. The conflict can have significant economic consequences, including currency fluctuations, inflation, and reduced purchasing power. These economic factors can influence healthcare budgets, potentially leading to reduced spending on medical devices, including spinal fusion devices.

The conflict can disrupt the supply chain of medical devices, including spinal fusion devices. Both countries play a significant role in the manufacturing and distribution of healthcare products. Any disruptions in transportation routes, border closures, or political tensions can lead to delays or interruptions in the availability of spinal fusion devices.

Segment Analysis

The global spinal fusion devices market is segmented based on product type, procedure location, application, end-user, and region.

Based on the Product Type, the Pedicle Screws Segment is Expected to Dominate the Market Share

Based on the product type, the pedicle screw segment is expected to dominate the market share accounting for 46.4% during the forecast period. Pedicle screws are widely used in spinal fusion surgeries to provide stability and support during the fusion process. Pedicle screws offer excellent stability by anchoring into the pedicles, which are bony protrusions on the vertebrae. This stability helps maintain proper alignment of the spine during the fusion process and promotes successful fusion.

Minimally invasive spinal fusion procedures have gained popularity due to their potential benefits, including smaller incisions, reduced muscle damage, and faster recovery. Pedicle screws are an essential component of minimally invasive approaches, enabling surgeons to achieve spinal fusion with less tissue disruption.

Geographical Analysis

North America Holds The Largest Market Share Of 38.5% Due To The Rising Prevalence Of Spinal Disorders And The Presence Of Major Players

North America holds the largest market share during the forecast period due to the rising prevalence of spinal disorders and the presence of major players. North America has a high prevalence of spinal disorders, including degenerative disc disease, herniated discs, and spinal stenosis. These conditions can cause severe pain and mobility issues, leading to the need for spinal fusion procedures. The increasing prevalence of these disorders drives the demand for spinal fusion devices in the region.

The presence of major players in this region, like Merck KGaA, Harvard Bioscience Inc. (BTX), Thermo Fisher Scientific, Inc., Bio-Rad Laboratories., and Lonza Group, are expected to boost the growth of the market over the forecast period.

Competitive Landscape

The major global players in the market include: Medtronic plc, Johnson & Johnson, Stryker Corporation, NuVasive Inc., Zimmer Biomet Holdings Inc., Globus Medical Inc., Spinal Elements Inc., Xtant Medical Holdings Inc., RTI Surgical Inc., and ATEC spine Inc.

Why Purchase the Report?

  • To visualize the global spinal fusion devices market segmentation based on product type, procedure location, application, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of spinal fusion devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global spinal fusion devices market report would provide approximately 54 tables, 46 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Procedure Location
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of spinal disorders
      • 4.1.1.2. Increasing demand for minimally invasive procedures
    • 4.1.2. Restraints
      • 4.1.2.1. High treatment costs
      • 4.1.2.2. Availability of alternative treatment options
    • 4.1.3. Opportunity
      • 4.1.3.1. Advancements in surgical techniques
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Pedicle Screws*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Plates
  • 7.4. Bone grafts
  • 7.5. Spinal fusion stimulators
  • 7.6. Others

8. By Procedure Location

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 8.1.2. Market Attractiveness Index, By Procedure Location
  • 8.2. Cervical spinal fusion devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Lumbar spinal fusion devices
  • 8.4. Thoracic spinal fusion devices
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Degenerative Disk Disease*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Spondylolisthesis
  • 9.4. Spinal stenosis
  • 9.5. Scoliosis
  • 9.6. Spinal trauma
  • 9.7. Tumors
  • 9.8. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory surgical clinics
  • 10.4. Specialty clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtronic plc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Johnson & Johnson
  • 13.3. Stryker Corporation
  • 13.4. NuVasive Inc.
  • 13.5. Zimmer Biomet Holdings Inc.
  • 13.6. Globus Medical Inc.
  • 13.7. Spinal Elements Inc.
  • 13.8. Xtant Medical Holdings Inc.
  • 13.9. RTI Surgical Inc.
  • 13.10. ATEC spine Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us